A Phase IV, Double-Blind, Placebo-Controlled, Randomized, Flexible Dose Study of the Safety and Efficacy of EMSAM in Adolescents With Major Depression.

Trial Profile

A Phase IV, Double-Blind, Placebo-Controlled, Randomized, Flexible Dose Study of the Safety and Efficacy of EMSAM in Adolescents With Major Depression.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2014

At a glance

  • Drugs Selegiline (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Somerset Pharmaceuticals
  • Most Recent Events

    • 28 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Feb 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
    • 02 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top